| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 10 |
| NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AQL0
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 258 | 262 | PF00656 | 0.434 |
| CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.525 |
| CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.372 |
| CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.525 |
| CLV_PCSK_PC1ET2_1 | 166 | 168 | PF00082 | 0.372 |
| CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.510 |
| CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.416 |
| CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.515 |
| DEG_APCC_DBOX_1 | 229 | 237 | PF00400 | 0.425 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.600 |
| DOC_CKS1_1 | 113 | 118 | PF01111 | 0.304 |
| DOC_PP1_RVXF_1 | 65 | 72 | PF00149 | 0.477 |
| DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.536 |
| DOC_USP7_UBL2_3 | 162 | 166 | PF12436 | 0.360 |
| DOC_USP7_UBL2_3 | 188 | 192 | PF12436 | 0.533 |
| DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.400 |
| DOC_WW_Pin1_4 | 264 | 269 | PF00397 | 0.545 |
| DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.417 |
| DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.468 |
| DOC_WW_Pin1_4 | 313 | 318 | PF00397 | 0.530 |
| DOC_WW_Pin1_4 | 323 | 328 | PF00397 | 0.629 |
| LIG_14-3-3_CanoR_1 | 167 | 176 | PF00244 | 0.533 |
| LIG_14-3-3_CanoR_1 | 291 | 299 | PF00244 | 0.337 |
| LIG_14-3-3_CanoR_1 | 4 | 13 | PF00244 | 0.540 |
| LIG_Actin_WH2_2 | 203 | 221 | PF00022 | 0.398 |
| LIG_Actin_WH2_2 | 285 | 300 | PF00022 | 0.497 |
| LIG_FHA_1 | 248 | 254 | PF00498 | 0.399 |
| LIG_FHA_1 | 284 | 290 | PF00498 | 0.583 |
| LIG_FHA_1 | 87 | 93 | PF00498 | 0.584 |
| LIG_FHA_2 | 133 | 139 | PF00498 | 0.302 |
| LIG_FHA_2 | 256 | 262 | PF00498 | 0.521 |
| LIG_FHA_2 | 304 | 310 | PF00498 | 0.505 |
| LIG_FHA_2 | 70 | 76 | PF00498 | 0.404 |
| LIG_FHA_2 | 85 | 91 | PF00498 | 0.356 |
| LIG_FHA_2 | 93 | 99 | PF00498 | 0.404 |
| LIG_LIR_Gen_1 | 124 | 134 | PF02991 | 0.398 |
| LIG_LIR_Gen_1 | 91 | 102 | PF02991 | 0.544 |
| LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.418 |
| LIG_LIR_Nem_3 | 79 | 84 | PF02991 | 0.406 |
| LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.496 |
| LIG_Rb_LxCxE_1 | 272 | 290 | PF01857 | 0.578 |
| LIG_SH2_NCK_1 | 246 | 250 | PF00017 | 0.525 |
| LIG_SH2_NCK_1 | 94 | 98 | PF00017 | 0.397 |
| LIG_SH2_STAP1 | 137 | 141 | PF00017 | 0.305 |
| LIG_SH2_STAT3 | 176 | 179 | PF00017 | 0.522 |
| LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.473 |
| LIG_SH2_STAT5 | 94 | 97 | PF00017 | 0.391 |
| LIG_SH3_3 | 60 | 66 | PF00018 | 0.486 |
| LIG_SUMO_SIM_anti_2 | 24 | 29 | PF11976 | 0.583 |
| LIG_SUMO_SIM_par_1 | 55 | 61 | PF11976 | 0.329 |
| LIG_TRAF2_1 | 45 | 48 | PF00917 | 0.447 |
| LIG_TYR_ITIM | 92 | 97 | PF00017 | 0.442 |
| LIG_UBA3_1 | 217 | 224 | PF00899 | 0.326 |
| LIG_UBA3_1 | 235 | 243 | PF00899 | 0.385 |
| LIG_WRC_WIRS_1 | 133 | 138 | PF05994 | 0.319 |
| LIG_WRC_WIRS_1 | 156 | 161 | PF05994 | 0.396 |
| MOD_CK1_1 | 103 | 109 | PF00069 | 0.384 |
| MOD_CK1_1 | 132 | 138 | PF00069 | 0.452 |
| MOD_CK1_1 | 316 | 322 | PF00069 | 0.688 |
| MOD_CK2_1 | 132 | 138 | PF00069 | 0.341 |
| MOD_CK2_1 | 92 | 98 | PF00069 | 0.455 |
| MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.411 |
| MOD_GSK3_1 | 103 | 110 | PF00069 | 0.370 |
| MOD_GSK3_1 | 28 | 35 | PF00069 | 0.589 |
| MOD_GSK3_1 | 299 | 306 | PF00069 | 0.445 |
| MOD_N-GLC_1 | 29 | 34 | PF02516 | 0.377 |
| MOD_NEK2_1 | 122 | 127 | PF00069 | 0.433 |
| MOD_NEK2_1 | 172 | 177 | PF00069 | 0.537 |
| MOD_NEK2_1 | 197 | 202 | PF00069 | 0.397 |
| MOD_NEK2_1 | 28 | 33 | PF00069 | 0.544 |
| MOD_NEK2_1 | 299 | 304 | PF00069 | 0.343 |
| MOD_NEK2_1 | 76 | 81 | PF00069 | 0.403 |
| MOD_NEK2_1 | 84 | 89 | PF00069 | 0.403 |
| MOD_NEK2_2 | 137 | 142 | PF00069 | 0.455 |
| MOD_PIKK_1 | 103 | 109 | PF00454 | 0.333 |
| MOD_PKA_2 | 122 | 128 | PF00069 | 0.513 |
| MOD_PKA_2 | 290 | 296 | PF00069 | 0.339 |
| MOD_Plk_1 | 137 | 143 | PF00069 | 0.401 |
| MOD_Plk_1 | 154 | 160 | PF00069 | 0.434 |
| MOD_Plk_1 | 92 | 98 | PF00069 | 0.427 |
| MOD_Plk_2-3 | 290 | 296 | PF00069 | 0.570 |
| MOD_Plk_2-3 | 93 | 99 | PF00069 | 0.454 |
| MOD_Plk_4 | 129 | 135 | PF00069 | 0.374 |
| MOD_Plk_4 | 137 | 143 | PF00069 | 0.313 |
| MOD_Plk_4 | 172 | 178 | PF00069 | 0.442 |
| MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.390 |
| MOD_ProDKin_1 | 264 | 270 | PF00069 | 0.547 |
| MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.424 |
| MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.472 |
| MOD_ProDKin_1 | 313 | 319 | PF00069 | 0.525 |
| MOD_SUMO_for_1 | 45 | 48 | PF00179 | 0.380 |
| MOD_SUMO_rev_2 | 124 | 133 | PF00179 | 0.547 |
| TRG_DiLeu_BaEn_1 | 295 | 300 | PF01217 | 0.532 |
| TRG_DiLeu_BaLyEn_6 | 265 | 270 | PF01217 | 0.542 |
| TRG_DiLeu_BaLyEn_6 | 80 | 85 | PF01217 | 0.376 |
| TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.524 |
| TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.531 |
| TRG_ER_diArg_1 | 78 | 81 | PF00400 | 0.393 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PBY5 | Leptomonas seymouri | 73% | 100% |
| A0A0S4J0C5 | Bodo saltans | 40% | 100% |
| A0A1X0NZ39 | Trypanosomatidae | 53% | 100% |
| A0A3R7MGA8 | Trypanosoma rangeli | 52% | 99% |
| A0A3S5H6X2 | Leishmania donovani | 94% | 100% |
| A4H8H8 | Leishmania braziliensis | 83% | 100% |
| A4HWV0 | Leishmania infantum | 94% | 100% |
| C9ZW37 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 98% |
| Q4QEW8 | Leishmania major | 91% | 100% |
| V5B947 | Trypanosoma cruzi | 51% | 100% |